Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Theraclone Sciences
Seattle Life Sciences Building
1124 Columbia Street, Suite 300
Seattle, WA 98104
Phone: 206-805-1600
www.theraclone-sciences.com

Theraclone Sciences is a Seattle-based biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The Company's I-STARô technology harnesses the power of the human immune system to identify rare, naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Theraclone has established discovery partnerships with Pfizer, Zenyaku Kogyo and the International AIDS Vaccine Research Initiative.

Key Contact
Name
Clifford Stocks
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/25/13 $8,000,000 Series B Alexandria Real Estate Equities
Amgen Business Development
ARCH Venture Partners
Canaan Partners
Healthcare Ventures
MidCap Financial
MPM Capital
Silicon Valley Bank
Versant Ventures
Zenyaku Kogyo
undisclosed
03/25/13 $6,000,000 Venture Debt


Featured Reading